{"organizations": [], "uuid": "6c4dd2527ed1e2e343c3524ba961e3a735b5f568", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/4", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/01/25/pr-newswire-vascular-insightsa-announces-new-chief-executive-officer.html", "country": "US", "domain_rank": 767, "title": "Vascular Insights® Announces New Chief Executive Officer", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-26T00:21:00.000+02:00", "replies_count": 0, "uuid": "6c4dd2527ed1e2e343c3524ba961e3a735b5f568"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/01/25/pr-newswire-vascular-insightsa-announces-new-chief-executive-officer.html", "ord_in_thread": 0, "title": "Vascular Insights® Announces New Chief Executive Officer", "locations": [], "entities": {"persons": [{"name": "directo", "sentiment": "negative"}, {"name": "james p. ott", "sentiment": "none"}, {"name": "jim", "sentiment": "none"}], "locations": [{"name": "mass.", "sentiment": "none"}, {"name": "quincy", "sentiment": "none"}], "organizations": [{"name": "microaire", "sentiment": "none"}, {"name": "colson associates", "sentiment": "none"}, {"name": "dana corporation", "sentiment": "none"}, {"name": "marmon group", "sentiment": "none"}, {"name": "paccar", "sentiment": "none"}, {"name": "berkshire hathaway", "sentiment": "none"}, {"name": "herrick-pacific corporation", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "QUINCY, Mass., Vascular Insights ® announced that its Board of Directors has appointed James P. Ott as President and CEO.\nJim brings to the position greater than 20 years of experience as President for companies in the manufacturing and medical device industries. He has held numerous leadership positions that have focused on the development and finance of the global commercialization, within companies including Dana Corporation, Paccar, Herrick-Pacific Corporation, The Marmon Group, and Berkshire Hathaway. Jim's most recent assignment was President of MicroAire medical devices, a member company of the Colson Associates, where he optimized the Company's commercial strategy for growth.\nVascular Insights ® is very enthusiastic to welcome Jim, and look forward to his contributions as we continue to expand our global commercial footprint. Jim commented, \"The ClariVein ® device is a quality product, with an innovative design, and an established safety profile that is unparalleled. We will continue to expand our reach to patients and physicians, while maintaining our commitment to best-in-class manufacturing and customer service.\"\nVascular Insights ® , LLC engages in the design, development, manufacturing and marketing of medical devices for the minimally invasive treatment of peripheral vascular disease. The ClariVein ® device has been used in more than 100,000 patients globally with excellent published results.\nIf you would like more information about this topic, please contact Chip Draper, Senior Vice President of Marketing and Strategy at 203.446.4907 or email at cdraper@vascularinsights.com .\nContact Chip Draper, Vice President of Marketing\nTelephone 203.446.4907\nEmail cdraper@vascularinsights.com\nWebsite www.VascularInsights.com\nView original content with multimedia: releases/vascular-insights-announces-new-chief-executive-officer-300588575.html\nSOURCE Vascular Insights, LLC", "external_links": ["http://www.prnewswire.com/news-releases/vascular-insights-announces-new-chief-executive-officer-300588575.html", "http://www.vascularinsights.com/"], "published": "2018-01-26T00:21:00.000+02:00", "crawled": "2018-01-26T01:22:06.013+02:00", "highlightTitle": ""}